Minimal model SI=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals
Open Access
- 1 March 2002
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 282 (3) , E564-E573
Abstract
The minimal model of glucose kinetics, in conjunction with an insulin-modified intravenous glucose tolerance test, is widely used to estimate insulin sensitivity (SI). Parameter estimation usually resorts to nonlinear least squares (NLS), which provides a point estimate, and its precision is expressed as a standard deviation. Applied to type 2 diabetic subjects, NLS implemented in MINMOD software often predicts SI=0 (the so-called “zero” SI problem), whereas general purpose modeling software systems, e.g., SAAM II, provide a very small SI but with a very large uncertainty, which produces unrealistic negative values in the confidence interval. To overcome these difficulties, in this article we resort to Bayesian parameter estimation implemented by a Markov chain Monte Carlo (MCMC) method. This approach provides in each individual the SI a posteriori probability density function, from which a point estimate and its confidence interval can be determined. Although NLS results are not acceptable in four out of the ten studied subjects, Bayes estimation implemented by MCMC is always able to determine a nonzero point estimate of SI together with a credible confidence interval. This Bayesian approach should prove useful in reanalyzing large databases of epidemiological studies.Keywords
This publication has 24 references indexed in Scilit:
- Maximum-likelihood versus maximum a posteriori parameter estimation of physiological system models: the c-peptide impulse response case studyIEEE Transactions on Biomedical Engineering, 2000
- Ability of Alternative Indices of Insulin Sensitivity to Predict Cardiovascular RiskAnnals of Epidemiology, 1998
- SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studiesMetabolism, 1998
- Markov Chain Monte Carlo in Practice.Journal of the American Statistical Association, 1997
- The GENNID Study: A resource for mapping the genes that cause NIDDMDiabetes Care, 1996
- Markov Chains for Exploring Posterior DistributionsThe Annals of Statistics, 1994
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988
- MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance testComputer Methods and Programs in Biomedicine, 1986
- Monte Carlo sampling methods using Markov chains and their applicationsBiometrika, 1970